Clinical Trial Update: Adjunctive Ivermectin Mass Drug Administration for Malaria Control [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on adjunctive ivermectin MDA for malaria control and related neglected tropical diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria
• Hookworm Infection
• Lymphatic Filariasis
• Malaria
• Neglected Tropical Diseases
• Scabies
• Soil-transmitted Helminthiasis
• Strongyloidiasis

Drugs mentioned

• IVERMECTIN (Ivermectin)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria,Falciparum, Neglected Tropical Diseases | Phase 3 | Status: UNKNOWN